Champions Oncology, Inc. (CSBR)

Market Cap	66.61M
Revenue (ttm)	49.22M
Net Income (ttm)	-9.73M
Shares Out	13.59M
EPS (ttm)	-0.72
PE Ratio	n/a
Forward PE	22.88
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,560
Open	4.730
Previous Close	4.740
Day's Range	4.730 - 4.930
52-Week Range	4.170 - 7.320
Beta	0.40
Analysts	Buy
Price Target	7.50 (+53.06%)
Earnings Date	Mar 12, 2024

About CSBR

Champions Oncology, Inc., a technology-enabled research company, provides transformative technology solutions for drug discovery and development in the United States. The company, through its Tumorgraft Technology Platform, provides personalized cancer care based upon the implantation of human tumors in immune-deficient mice. It also offers Translational Oncology Solutions that utilizes its technology platform to assist pharmaceutical and biotechnology companies with their drug development process. In addition, it offers Lumin Bioinformatics, a...

• Industry: Biotechnology
• Sector: Healthcare
• IPO Date: Mar 25, 1986
• Employees: 230
• Stock Exchange: NASDAQ
• Ticker Symbol: CSBR

Analyst Forecast

According to 2 analysts, the average rating for CSBR stock is "Buy." The 12-month stock price forecast is $7.5, which is an increase of 53.06% from the latest price.

Price Target

$7.5

(53.06% upside)

Analyst Consensus: Buy